36
Participants
Start Date
July 31, 2015
Primary Completion Date
October 31, 2016
Study Completion Date
October 31, 2016
somavaratan
Long-acting recombinant human growth hormone therapy administered subcutaneously once monthly
The Alfred Hospital, Melbourne
St Vincent's Hospital, Fitzroy
Princess Alexandra Hospital, Woolloongabba
Charite-Universitätsmedizin, Berlin
Endocrine Associates of Dallas, Plano
Palm Research Center, Las Vegas
Cedars-Sinai Medical Center, Los Angeles
AMCR Institute Inc., Escondido
Therapeutic Research Institute of Orange County, Laguna Hills
Stanford University, Stanford
Swedish Medical Center, Seattle
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Universitätsklinikum Essen, Essen
Queen Elizabeth Hospital, Birmingham
William Harvey Research Institute, London
Hull Royal Infirmary, Hull, East Yorkshire
The Christie NHS Foundation Trust, Manchester
Collaborators (1)
Premier Research Group plc
UNKNOWN
Versartis Inc.
INDUSTRY